IL1B and diabetes mellitus: In the groups of TB patients with impaired leukocyte ROS production, including the patients with diabetes mellitus, higher disease severity and poorer treatment outcome have been attributed to high levels of pro-inflammatory cytokines, including IL-1β, in the tissue [8, 44, 45].